John F. Vavricka
Chief Commercial OfficerMr. John F. Vavricka has been the Chief Commercial Officer of Atea Pharmaceuticals, Inc. since October 2018. Mr. Vavricka cofounded Biothea Pharma, Inc. in 2015. Mr. Vavricka cofounded an served as the Chief Executive Officer of Biothea Pharma, Inc., a biotechnology company, from March 2018 to June 2021. He was a Co-Founded of Iroko Pharmaceuticals, LLC in 2007. He served as the Chief Executive Officer and President of Iroko Pharmaceuticals, LLC since May 2007 until 2015. Mr. Vavricka overseen the day-to-day operations of Iroko Pharmaceuticals and focuses on maximizing the potential of existing brands, securing additional acquisitions and building infrastructure for future growth. He was the Founder, Chief Executive Officer and President of Iroko Pharmaceuticals, Inc. from 2007 to 2015. Mr. Vavricka has served numerous executive positions in sales, marketing, and research & development in biotech & pharmaceutical companies, both global and locally operating companies. Mr. Vavricka has experience in the pharmaceutical industry. From April 2011 to December 2012, Mr. Vavricka served as Secretary of iCeutica. From 2003 to 2007, Mr. Vavricka served as Vice President of US & European Commercial Operations for Chiron Vaccines (now Novartis Vaccines, a subsidiary of Novartis Pharmaceuticals). From 2001 to 2003, Mr. Vavricka served as Vice President of Marketing of GlaxoSmithKline plc. At GlaxoSmithKline plc, Mr. Varicka led the integration of GlaxoSmithKline plc’s predecessor companies in Canada. From 1999 to 2001, he served as Vice President of Global Product Strategy for R&D, he headed strategy and commercial development for cardiovascular and urogenital therapies. From 1987 to 1999 at SmithKline Beecham, a predecessor of GlaxoSmithKline plc, he held positions of increasing responsibility, lastly as Regional Vice President of Sales. Mr. Vavricka holds a B.A. degree in Neurobiology/Physiology and B.S. from Northwestern University.
Positions
- Company NameAtea Pharmaceuticals, Inc.Stock CodeAVIRPositionChief Commercial OfficerColleagues
- JSJean-Pierre SommadossiFounder, Chairman, CEO & President
- AJAndrea J. CorcoranCFO, Executive VP of Legal & Secretary
- JMJanet M. J. HammondChief Development Officer
- MAMaria Arantxa HorgaChief Medical Officer
- FMFranklin M. BergerLead Independent Director
- PAPolly A. MurphyIndependent Director
- BGBarbara G. DuncanIndependent Director
- BLBruno LucidiIndependent Director
